iShares Biotechnology ETF (IBB)
172.39
+0.13
(+0.08%)
USD |
NASDAQ |
Jan 09, 16:00
172.50
+0.11
(+0.06%)
After-Hours: 20:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.44% | -0.00% | 8.603B | 1.704M |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.50% | 18.00% | 341.98M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the investment results of the ICE Biotechnology Index, which measures the performance of US-listed securities of companies that are classified within the Biotechnology Sub-Industry Group. The Fund generally invests at least 90% of its assets in securities of the Underlying Index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | BlackRock |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of January 11, 2026.
Asset Allocation
As of December 31, 2025.
| Type | % Net |
|---|---|
| Cash | -0.33% |
| Stock | 99.91% |
| Bond | 0.45% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | -0.03% |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the investment results of the ICE Biotechnology Index, which measures the performance of US-listed securities of companies that are classified within the Biotechnology Sub-Industry Group. The Fund generally invests at least 90% of its assets in securities of the Underlying Index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | BlackRock |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |